Ann: Appendix 3B - lapse of options-IVX.AX, page-11

Cooko55, it's good to hear from a long term holder. Surely now after all these years of waiting shareholders will be rewarded with a deal ( like you I bought shares way back at $3). No one has ever doubted the science, not so with capital management and time lines. Nevertheless the clock is ticking towards 12....
the company is running on nearly on empty, but replying to query from asx, no immediate plans to raise capital
1.2 million in directors loans fall due July 14
NIMA results due ... my guess end of July ( only based on how long it took smoking cessation results last year from final dose )
Understandably any deal would be subject to NIMA data. Dr Glass hinted as much when he said last month that the smoking cessation results when taken with the clinical biomarker and biopsy data available from the NIMA trial later this year ' we should then gain a clear picture of the impact of nadolol on airway disease.'